SEC Form 4 · accession 0001610717-26-000387
Revolution Medicines, Inc. · RVMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Goldsmith
Officer — See Remarks · Director
Period of report
Aug 21, 2026
Accepted (ET)
Aug 25, 2026 · 4:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001628171
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 21, 2026 | M | 80,000 | $4.73 | A | 347,330 | D | |
| Common StockF3,F2 | Aug 21, 2026 | S | 5,128 | $207.233 | D | 342,202 | D | |
| Common StockF4,F2 | Aug 21, 2026 | S | 24,917 | $208.3697 | D | 317,285 | D | |
| Common StockF5,F2 | Aug 21, 2026 | S | 35,938 | $209.2615 | D | 281,347 | D | |
| Common StockF6,F2 | Aug 21, 2026 | S | 3,813 | $210.2466 | D | 277,534 | D | |
| Common StockF7,F2 | Aug 21, 2026 | S | 6,583 | $211.3331 | D | 270,951 | D | |
| Common StockF8,F2 | Aug 21, 2026 | S | 3,621 | $212.0776 | D | 267,330 | D | |
| Common StockF9,F10 | Aug 21, 2026 | S | 190 | $207.2454 | D | 64,234 | I | Trust |
| Common StockF11,F10 | Aug 21, 2026 | S | 951 | $208.3648 | D | 63,283 | I | Trust |
| Common StockF12,F10 | Aug 21, 2026 | S | 1,351 | $209.2812 | D | 61,932 | I | Trust |
| Common StockF13,F10 | Aug 21, 2026 | S | 136 | $210.4017 | D | 61,796 | I | Trust |
| Common StockF14,F10 | Aug 21, 2026 | S | 245 | $211.4651 | D | 61,551 | I | Trust |
| Common StockF15,F10 | Aug 21, 2026 | S | 127 | $212.0635 | D | 61,424 | I | Trust |
| Common StockF9,F16 | Aug 21, 2026 | S | 177 | $207.2515 | D | 64,247 | I | Trust |
| Common StockF17,F16 | Aug 21, 2026 | S | 937 | $208.3609 | D | 63,310 | I | Trust |
| Common StockF18,F16 | Aug 21, 2026 | S | 1,405 | $209.2664 | D | 61,905 | I | Trust |
| Common StockF13,F16 | Aug 21, 2026 | S | 126 | $210.403 | D | 61,779 | I | Trust |
| Common StockF14,F16 | Aug 21, 2026 | S | 229 | $211.4648 | D | 61,550 | I | Trust |
| Common StockF15,F16 | Aug 21, 2026 | S | 126 | $212.0641 | D | 61,424 | I | Trust |
| Common StockF19 | holding | — | — | — | 594,060 | I | Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.73 | Aug 21, 2026 | M | 80,000 | D | Aug 9, 2023 | Aug 8, 2029 | Common Stock | 80,000 | 344,085 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
- F10Held by Jonathan Goldsmith Revocable Trust.
- F11This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16Held by Rebecca Goldsmith Revocable Trust.
- F17This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F18This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F19Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
- F2Includes 182,938 restricted stock units.
- F3This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks
President and Chief Executive Officer